• Call(WhatsApp Us)

    +8615360806100
  • Email Us

    cherry@laeyo.com
  • 广州市花都区花山镇华辉路18号

    微观化妆品创意产业园E栋整栋

Cleansing Balm vs Gel Cleanser: How to Choose a Hero Makeup-Removal Product for U.S. Retail

A hero makeup-removal product is the SKU a shopper rebuys without thinking — and in U.S. retail it is usually a cleansing balm or a gel cleanser. Both can carry a "cleansing" claim, both…

Category: Body Care Sourcing Guides • Author: laeyo • Published: 2026-11-15 • Views: 18

A hero makeup-removal product is the SKU a shopper rebuys without thinking — and in U.S. retail it is usually a cleansing balm or a gel cleanser. Both can carry a “cleansing” claim, both can sit on the same shelf, and both can fail in completely different ways after the purchase order is signed. This guide is written for brand owners and sourcing managers who need to pick a format, lock a specification, and know exactly which documents and tests to demand before the first production run. Informational only, not legal advice.

Quick answer: which format should be your hero

  • Choose a cleansing balm if your shopper wears long-wear or waterproof makeup, has dry or reactive skin, and expects a sensorial, massage-like ritual. The oil phase dissolves pigment and film-formers that water-based surfactants struggle with.
  • Choose a gel cleanser if your shopper is oily or combination, wants a fast rinse with no residue, and buys on “lightweight” and “non-greasy” language. Expect a lower unit cost and a simpler packaging path.
  • The highest-leverage decision is not the format — it is the removal target. Define what the product must remove (waterproof mascara, transfer-proof foundation, SPF film) before you brief a single formula.
  • The second decision is packaging. A balm lives or dies on heat stability and jar/tube compatibility; a gel lives or dies on pump dose and viscosity drift.
  • The third decision is claim scope. “Cleansing” and “makeup removal” are cosmetic intended uses in the U.S., which keeps drug risk low — but every claim still needs finished-product evidence, not an ingredient story.
  • Request immediately: finished-product cleansing/makeup-removal efficacy data, accelerated and real-time stability, preservative efficacy (challenge) test, packaging compatibility report, and a batch-level COA with pH, viscosity, and micro results.

What “hero makeup remover” actually means for U.S. retail

U.S. buyers evaluate a hero SKU on four axes that are easy to conflate: performance, sensory, compliance, and operational repeatability. A balm that removes everything but leaves a milky film will get returned. A gel that rinses clean but cannot lift waterproof mascara will get one-star reviews. A formula that does both but cannot survive a July truck will get a chargeback.

Under U.S. cosmetic intended-use principles, products that clean the skin and remove makeup are cosmetics, not drugs, provided the labeling does not make therapeutic claims (for example, treating acne, killing bacteria, or “healing” the skin barrier). That keeps the regulatory pathway light — but it does not remove the obligation to substantiate what the label says. Facility registration, product listing, adverse-event reporting, and safety substantiation records are now part of the U.S. operating baseline; confirm current FDA timelines and requirements with your regulatory lead before you plan a launch date.

Decision tree: pick the format in six questions

  • Start here — does the product need to remove waterproof or long-wear makeup? If yes, lean balm or a balm-to-milk hybrid. If no, gel is viable.
  • Is the primary skin type dry, sensitive, or reactive? If yes, lean balm or a low-surfactant gel with a mild pH. If oily or combination, lean gel.
  • Does the shopper expect a ritual or a routine? Ritual (massage, emulsify, cloth) favors balm. Routine (30-second rinse in the shower) favors gel.
  • Is the channel mass, masstige, or prestige specialty? Prestige and specialty shelves tolerate balms at higher price points; mass and value tiers favor gels on cost per use.
  • Can you fund a jar-format preservative strategy and heat-stability testing? If not, choose a tube or a gel.
  • Boundary cases: if you want a single SKU that serves both dry and oily skin, or if you plan to sell into the EU/UK as well as the U.S., or if you intend any therapeutic-adjacent language (“purges pores,” “calms acne”), stop and route the brief through regulatory counsel and additional testing before tooling.

Balm vs gel: a sourcing comparison

Sourcing dimension Cleansing balm Gel cleanser Evidence to request
Removal performance Strong on waterproof mascara and long-wear base; depends on oil blend and emulsifier system Strong on light makeup, sweat, and sebum; weaker on film-formers unless boosted Finished-product makeup-removal efficacy protocol and results on a defined substrate set
After-feel Rich, cushiony; risk of residue or milky film if emulsification is incomplete Light, fast-rinsing; risk of tightness if surfactant load or pH is too high Consumer sensory panel data plus rinse-off residue / hard-water test
pH and barrier Typically low-water; pH less critical but emulsifier mildness matters Target mildly acidic to neutral, roughly pH 5.5–7.0; alkaline systems near pH 9–10 are harsher on sensitive skin Batch COA with pH spec and release limits
Packaging Jar, tube, or stick; heat and oil migration are the main risks Tube or pump; viscosity and dose uniformity are the main risks Packaging compatibility report including weight loss, odor transfer, and dispensing test
Stability Needs elevated-temperature and freeze-thaw data for syneresis and texture Needs viscosity drift and clarity/color data over time Accelerated (typically 12-week at 40°C) plus real-time stability summary
Microbiology Higher risk in jars; open-pan and finger contamination Lower risk in sealed tubes and pumps Preservative efficacy test (challenge test) plus release and 12-week micro counts
Cost and fill Higher raw-material cost, heavier fill, premium price support Lower raw-material cost, easier to scale Costed bill of materials and fill-weight control plan
Claims fit Supports “melts makeup,” “no tugging,” “ritual” Supports “lightweight,” “non-greasy,” “daily cleanse” Claim substantiation file mapping each on-pack phrase to a test or published reference

Formulation guardrails worth writing into the brief

Cleansing balm

  • Specify the melt point and the texture at 25°C and at 32–35°C, so the product softens on skin but does not collapse in transit.
  • Require a defined emulsifier system and a rinse test in both soft and hard water; incomplete emulsification is the number-one cause of the “film” complaint.
  • Ask for an oil-migration and skin-feel assessment with the actual fragrance, because fragrance and emollient interaction is a common source of both texture change and packaging staining.
  • Decide jar versus tube early. A jar raises preservative and contamination expectations; a tube constrains viscosity and fill temperature.

Gel cleanser

  • Set a pH window and a release tolerance in the specification, not just a target value.
  • If the marketing story is “sulfate-free,” pair it with finished-product cleansing efficacy data; a mild surfactant system that does not clean is a returns problem, not a selling point.
  • Define viscosity at a stated shear rate and temperature, and require a 12-week viscosity drift limit — pumps are engineered around a dose, not a range.
  • Confirm compatibility with the intended pump or tube orifice before you approve artwork.

Minimum evidence pack to request from your manufacturer

A) Compliance and filings

  • Request: Confirmation of facility registration status and product listing readiness for the U.S. market.

    Evidence: Facility registration confirmation and a listing data template.

    Owner: Manufacturer.

    Acceptance criteria: Written confirmation dated within the current compliance cycle, with the legal manufacturer name matching the label.
  • Request: Intended-use statement for the formula.

    Evidence: Signed cosmetic intended-use declaration covering cleansing and makeup removal, with no therapeutic language.

    Owner: Manufacturer / Buyer.

    Acceptance criteria: Declaration references the exact SKU and is consistent with all on-pack copy.

B) Testing and substantiation

  • Request: Finished-product makeup-removal and cleansing efficacy data.

    Evidence: Efficacy protocol plus results (instrumental or sensory/physical, depending on the claim), including removal of a defined waterproof mascara or long-wear foundation.

    Owner: Lab.

    Acceptance criteria: Results are from the finished formula and the production-intent fragrance and color, not a bench prototype.
  • Request: Stability program.

    Evidence: Accelerated stability summary (commonly 12 weeks at 40°C plus freeze-thaw cycles) and real-time data to date.

    Owner: Manufacturer / Lab.

    Acceptance criteria: pH, viscosity or texture, color, odor, and micro results stay within spec for the full study, with no syneresis in the balm or phase separation in the gel.
  • Request: Preservative efficacy and release microbiology.

    Evidence: Challenge test report and batch micro results against a stated specification.

    Owner: Lab.

    Acceptance criteria: Challenge test passes at release and after the stability interval; micro results are within the agreed limits for every production batch.

C) Labeling and claims

  • Request: Draft ingredient declaration matched to the actual formula version.

    Evidence: INCI list with a version number and a cross-check against the batch manufacturing record.

    Owner: Manufacturer / Buyer.

    Acceptance criteria: Zero discrepancies between the INCI on artwork, the COA, and the formula version in the batch record.
  • Request: Claim substantiation mapping.

    Evidence: A line-by-line table pairing each on-pack and e-commerce phrase with its supporting test or reference.

    Owner: Buyer / Manufacturer.

    Acceptance criteria: Every claim has a named evidence source; unsupported phrases are removed before artwork approval.

D) QA, traceability, and audit readiness

  • Request: Batch documentation package.

    Evidence: COA, batch manufacturing record, SDS with current revision date, and a retained-sample policy.

    Owner: Manufacturer.

    Acceptance criteria: Package is delivered with the first production batch, not after launch; SDS revision date is within the last three years.
  • Request: Packaging compatibility file.

    Evidence: Compatibility report covering formula-to-pack contact, weight loss, odor and color transfer, and dispensing or closure performance.

    Owner: Packaging supplier / Manufacturer.

    Acceptance criteria: Report covers the exact decorated component, not just the base resin, and includes the final label adhesive and substrate pairing.

Do NOT cut: red lines

  • Do not skip finished-product efficacy testing. Ingredient stories and “sulfate-free” positioning are not removal evidence.
  • Do not shorten stability. A 4-week abbreviated study is a risk transfer to your customer, not a shortcut.
  • Do not waive the challenge test on a jar format. Open-pan balms carry a materially higher contamination risk.
  • Do not approve artwork before the INCI, net content, and claims are locked against the final formula version.
  • Do not accept a packaging compatibility report that was run on an undecorated stock component when your product uses a custom closure, a soft-touch coating, or a special adhesive label.
  • Do not let “clean” mean “fear-based.” Define what your brand’s clean standard actually is — screening criteria, transparency, and performance targets — rather than leading with what has been removed. Every clean, vegan, or cruelty-free claim needs a verifiable standard behind it.

Realistic U.S. launch timeline

Standard path (lower risk, roughly 22–26 weeks)

  • Weeks 1–2 — Brief and benchmark. Buyer: define removal targets, skin types, price tier, and channel. Manufacturer: benchmark two or three reference products and propose bases. Evidence output: signed product brief and benchmark summary.
  • Weeks 3–6 — Formula development. Buyer: approve one lead and one backup prototype. Manufacturer: iterate texture, rinse feel, and fragrance. Evidence output: prototype submission sheet with pH and viscosity or texture targets.
  • Weeks 5–16 — Stability and packaging compatibility. Buyer: lock the component and decoration. Manufacturer: start accelerated stability in the final pack. Evidence output: interim stability report and compatibility report.
  • Weeks 8–14 — Efficacy and microbiology. Buyer: approve the claim list. Lab: run makeup-removal efficacy and challenge testing. Evidence output: efficacy report and preservative efficacy report.
  • Weeks 12–17 — Label and claims review. Buyer: route artwork through regulatory. Manufacturer: issue the final INCI and specification. Evidence output: approved artwork with a signed claim substantiation file.
  • Weeks 17–21 — Pilot run. Buyer: approve the pilot batch against the golden reference. Manufacturer: run pilot, fill, and hold. Evidence output: pilot batch record and COA.
  • Weeks 21–26 — Production and documentation handoff. Manufacturer: full run plus the complete documentation package. Evidence output: final COA, SDS, stability summary, micro results, and compatibility file.

Fastest safe path (roughly 16–18 weeks)

Compress by selecting a pre-validated base and a stock component, running efficacy and stability in parallel from week 4, and locking claims before the pilot rather than after. You may compress prototype rounds and artwork cycles. You may not compress the stability interval, the challenge test, or the documentation review — those are where recalls and chargebacks originate.

Common failure modes and how to prevent them

  • Symptom: Balm arrives grainy, sweating, or collapsed in the jar.

    Root cause: Insufficient heat-stability margin in the wax-to-oil ratio, or transit temperatures above the tested range.

    Prevention: Specify a melt point with headroom above realistic warehouse and truck temperatures, and test the finished product in the final jar.

    What to request from factory: Stability protocol including 40°C and freeze-thaw cycling, plus a droop or texture measurement at elevated temperature.
  • Symptom: The gel will not dispense a consistent dose, or the pump spits.

    Root cause: Viscosity drift or a shear-thinning profile that does not match the pump’s stroke volume.

    Prevention: Validate the formula in the actual pump before tooling; set a viscosity window at a defined shear rate and temperature.

    What to request from factory: Pump dispensing test (dose uniformity across the first and last tenths of the pack) and a 12-week viscosity drift report.
  • Symptom: Labels lift, wrinkle, or bleed oil on the balm jar after a few weeks on shelf.

    Root cause: Adhesive and substrate mismatch combined with oil migration to the container surface — a classic packaging compatibility failure.

    Prevention: Pair the adhesive to the actual decorated substrate and validate with the finished formula inside.

    What to request from factory: Label adhesion test results (cross-hatch or equivalent), substrate specification, and a compatibility report that includes the decorated component.
  • Symptom: Fragrance smells different, or the tube discolors, after storage.

    Root cause: Interaction between fragrance components and the plastic or elastomer, or oxidation of the oil phase.

    Prevention: Run compatibility with the final fragrance at the final dose, and set an oxidation indicator in the specification.

    What to request from factory: Packaging compatibility report covering odor transfer, color change, and weight loss, plus an antioxidant strategy for the oil phase.
  • Symptom: Customers report a milky film or a tight, squeaky after-feel.

    Root cause: Incomplete emulsification in the balm, or excessive surfactant load and an alkaline pH in the gel.

    Prevention: Test rinse performance in both soft and hard water, and hold the gel to a mildly acidic to neutral pH window rather than an alkaline one.

    What to request from factory: Rinse-off residue test, hard-water rinse data, and batch COA with pH release limits.
  • Symptom: The product is reviewed as not removing waterproof mascara despite “removes makeup” on pack.

    Root cause: Claim written from ingredient logic rather than finished-product performance.

    Prevention: Define the removal substrate set in the brief and test the finished formula against it.

    What to request from factory: Makeup-removal efficacy protocol naming the specific long-wear and waterproof substrates, with results on the production-intent formula.
  • Symptom: Retailer onboarding stalls on paperwork, or a batch is rejected at audit.

    Root cause: Documentation failure — a missing or expired COA, an SDS past revision, an INCI mismatch between artwork and batch record, or incomplete stability and micro files.

    Prevention: Build a document control matrix at kickoff and treat the documentation package as a deliverable, not an afterthought.

    What to request from factory: Batch COA, current SDS, stability summary, micro results, formula version log, and a named QA contact responsible for document release.
  • Symptom: Micro counts drift upward in a jar format over the shelf life.

    Root cause: Preservative system designed for a tube applied to an open-pan product with finger contact.

    Prevention: Match the preservative strategy to the format and validate at the stability interval, not only at release.

    What to request from factory: Challenge test report plus micro results at release and after the stability interval, with the sampling plan stated.

Copy-paste RFQ checklist for your manufacturer

Share target market (U.S.) and retail channel.
Confirm intended use: cleansing and makeup removal, cosmetic only.
Provide the removal target list (waterproof mascara, long-wear foundation, SPF).
State skin-type focus and any free-from constraints.
Confirm the format decision: balm, gel, or hybrid.
Attach reference products and benchmark pricing.
Request finished-product makeup-removal efficacy protocol and results.
Request accelerated stability summary plus real-time data to date.
Request freeze-thaw data if the format is a balm.
Request preservative efficacy (challenge) test with release and interval micro results.
Request batch COA template showing pH, viscosity, and micro specs.
Request SDS with current revision date.
Confirm facility registration status and product listing readiness.
Provide draft INCI and confirm it matches the formula version.
Attach current artwork for label and claims review.
Request claim substantiation mapping for every on-pack phrase.
Confirm net content and fill-weight control plan.
Lock the component, decoration, and label adhesive before testing.
Request packaging compatibility report on the decorated component.
Request pump dispensing or closure performance data where applicable.
Confirm the pilot batch size and approval criteria.
Agree the documentation package contents and delivery date.
Name the QA contact responsible for document release.
Confirm production lead time and first-ship date.

FAQ

Is a cleansing balm suitable for oily or combination skin?

Yes, if the emulsifier system rinses completely and the oil blend is non-comedogenic by design. The failure mode is residue, not oil itself. Ask for rinse-off residue data in hard water and a clear after-feel description from a sensory panel before you position it for oily skin.

My gel cleanser says “removes makeup.” Do I still need a separate remover?

Only if the claim is substantiated against the makeup your customer actually wears. Many gels handle light base and sunscreen but struggle with waterproof eye makeup. Test the finished product against your defined substrate set and let the result decide the claim, not the other way around.

Is “cleansing” a drug claim in the U.S.?

No. Cleaning the skin and removing makeup are cosmetic intended uses, which keeps drug risk low. The line is crossed by therapeutic language — treating acne, killing bacteria, or repairing the barrier. Keep the copy within cosmetic intended use and substantiate every performance claim with finished-product data.

What pH should a gel cleanser target?

A mildly acidic to neutral window, roughly pH 5.5–7.0, is the safer choice for sensitive skin. Alkaline systems near pH 9–10 are associated with greater irritation potential, particularly for consumers who describe themselves as sensitive. Write the window and the release tolerance into the specification.

Can one formula serve as both a facial and a body cleansing balm?

Often yes, and it is a sensible way to extend a hero SKU into body care. Confirm that the texture performs at body-application volumes, that the packaging holds up in a wet shower environment, and that the label claims are appropriate for both use sites before you commit to a single fill.

Next step

If you are ready to compare a balm and a gel against the same brief, send your target market, SKU list and formats, positioning, packaging direction, and launch timeline. A complete brief shortens the benchmarking phase and produces a faster, more accurate quote.

Request a Quote

Hi, I'm your LAEYO representative, hope you like this blog post.

With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.

  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).